SRTA on XNAS, Transportation, Strata Critical Medical, Inc., job postings
Measures activity, not value. Not investment advice.
Quarterly revenue jumped 50% to $74.1M but the stock is down 26% in six months.
BadStill lost $24.8M over the last 12 months
GoodInstitutional holders rose 18% to 164 from the prior quarter
Written by AI from the data on this page, 22 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.
expected around 2 Mar 2027 (an estimate: a year ago it reported on 3 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $74.1M, net loss $7.6M.
31 Dec 2021RevenueNet incomeNet losstallest bar $74.9M30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$74.1M
-$7.6M
30 Jun 2026
$72.5M
-$10.5M
31 Mar 2026
$67.4M
$2.2M
31 Dec 2025
–
-$8.8M
30 Sep 2025
$49.3M
$57.4M
30 Jun 2025
$70.8M
-$3.7M
31 Mar 2025
$54.3M
-$3.5M
31 Dec 2024
$54.4M
-$9.8M
30 Sep 2024
$74.9M
-$2.0M
30 Jun 2024
$67.9M
-$11.3M
31 Mar 2024
$51.5M
-$4.2M
31 Dec 2023
$47.5M
-$33.9M
30 Sep 2023
$71.4M
$289K
30 Jun 2023
$61.0M
-$12.2M
31 Mar 2023
$45.3M
-$10.2M
31 Dec 2022
$38.1M
-$27.3M
30 Sep 2022
$45.7M
-$9.2M
30 Jun 2022
$35.6M
$8.4M
31 Mar 2022
$26.6M
-$11.0M
31 Dec 2021
$24.6M
$772K
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$280.8M
$184.7M
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+52%
+9.8%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
-$24.8M
$40.4M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
-$0.30
$0.49
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
21.6%
21.3%
18.7%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
-6.6%
-13.2%
4.9%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
-8.8%
21.9%
1.0%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
-8.9%
-5.7%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
–
-$54.7M
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$41.6M
$75.9M
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
–
$0
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
–
-$75.9M
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
–
1.3
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$3.09
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
loss
16.0
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
1.5
2.0
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
–
2.7
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
1.5
1.7
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
+$10K
bought $10K, sold $0
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
+18%
164 13F filers vs 139
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
63%
55.9M shares held by 13F filers (30 Sep 2026) of 89.3M outstanding (26 Oct 2026)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
5.1%
4.6M shares sold short (30 Oct 2026) of 89.3M outstanding (26 Oct 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
5.0
4.6M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
+0.3%
4.5M shares sold short in the report before, 4.6M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
61%
61% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 47%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
22
Tracked since 20 Nov 2026
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
Tracking started 20 Nov 2026; the change shows after 30 days.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
–
No data for this company
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+50%
$74.1M vs $49.3M (quarter ended 30 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
-86%
$400K vs $2.8M (quarter ended 30 Sep 2026)
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
–
No data for this company
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
$120K
4 quarters, $
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
–
No data for this company
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
6
6 articles in the last 7 days; its usual week has 3 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
2.0×
6 articles in the last 7 days; its usual week has 3.
Unusual now sharp changes in the last 90 days, compared with its own past
New institutional positions 47, 2.0× a year earlier
Price $4.56 on 20 Nov 2026, +13% over 12 months (12-month range $4.03 to $6.47)
Sharp change
8-K and other filings
Lobbying filing
Insider net buying (open market). Insiders sold a net $724K in the last 12 months (the 12 months before: -$2.7M).Revenue per quarter. Revenue $74.1M in the latest quarter, +50% on a year earlier.Capital spending per quarter. Capital spending $400K in the latest quarter, -86% on a year earlier.Institutional holders (13F filers). 164 13F filers reported holding it in the latest 13F quarter, +28% on a year earlier.Lobbying spend. Lobbying spend: $120K published in the last 12 months (none in the 12 months before).
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, workers in warn layoff notices.
Quarter ended 30 Sep 2020: $8.3M; public on 21 Dec 2021
Quarter ended 31 Mar 2021: $9.3M; public on 11 May 2022
Quarter ended 30 Sep 2021: $20.3M, +144% on a year earlier; public on 11 Nov 2022
Quarter ended 31 Dec 2021: $24.6M; public on 17 Mar 2023
Quarter ended 31 Mar 2022: $26.6M, +187% on a year earlier; public on 11 May 2022
Quarter ended 30 Jun 2022: $35.6M, +175% on a year earlier; public on 10 Aug 2022
Quarter ended 30 Sep 2022: $45.7M, +125% on a year earlier; public on 11 Nov 2022
Quarter ended 31 Dec 2022: $38.1M, +55% on a year earlier; public on 17 Mar 2023
Quarter ended 31 Mar 2023: $45.3M, +70% on a year earlier; public on 12 May 2023
Quarter ended 30 Jun 2023: $61.0M, +71% on a year earlier; public on 10 Aug 2023
Quarter ended 30 Sep 2023: $71.4M, +56% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $47.5M, +24% on a year earlier; public on 13 Mar 2024
Quarter ended 31 Mar 2024: $51.5M, +14% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $67.9M, +11% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $74.9M, +4.8% on a year earlier; public on 13 Nov 2024
Quarter ended 31 Dec 2024: $54.4M, +14% on a year earlier; public on 14 Mar 2025
Quarter ended 31 Mar 2025: $54.3M, +5.4% on a year earlier; public on 13 May 2025
Quarter ended 30 Jun 2025: $70.8M, +4.2% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $49.3M, -34% on a year earlier; public on 11 Nov 2025
Quarter ended 31 Mar 2026: $67.4M, +24% on a year earlier; public on 7 May 2026
Quarter ended 30 Jun 2026: $72.5M, +2.4% on a year earlier; public on 5 Aug 2026
Quarter ended 30 Sep 2026: $74.1M, +50% on a year earlier; public on 4 Nov 2026
Capital spending per quarter
Quarter ended 31 Mar 2021: $53K; public on 11 May 2022
Quarter ended 30 Jun 2021: $144K; public on 10 Aug 2022
Quarter ended 30 Sep 2021: $67K; public on 11 Nov 2022
Quarter ended 31 Dec 2021: $224K; public on 17 Mar 2023
Quarter ended 31 Mar 2022: $437K, +725% on a year earlier; public on 11 May 2022
Quarter ended 30 Jun 2022: $189K, +31% on a year earlier; public on 10 Aug 2022
Quarter ended 30 Sep 2022: $93K, +39% on a year earlier; public on 11 Nov 2022
Quarter ended 31 Dec 2022: $11K, -95% on a year earlier; public on 17 Mar 2023
Quarter ended 31 Mar 2023: $646K, +48% on a year earlier; public on 12 May 2023
Quarter ended 30 Jun 2023: $744K, +294% on a year earlier; public on 10 Aug 2023
Quarter ended 30 Sep 2023: $695K, +647% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Mar 2024: $816K, +26% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $16.2M, +2072% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $9.3M, +1240% on a year earlier; public on 13 Nov 2024
Quarter ended 31 Dec 2024: $4.6M; public on 14 Mar 2025
Quarter ended 31 Mar 2025: $2.6M, +221% on a year earlier; public on 13 May 2025
Quarter ended 30 Jun 2025: $2.3M, -86% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $2.8M, -70% on a year earlier; public on 11 Nov 2025
Quarter ended 31 Dec 2025: $1.8M, -60% on a year earlier; public on 4 Mar 2026
Quarter ended 31 Mar 2026: $5.2M, +98% on a year earlier; public on 7 May 2026
Quarter ended 30 Sep 2026: $400K, -86% on a year earlier; public on 4 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 74; public on 14 Feb 2022
31 Mar 2022 report: 74; public on 16 May 2022
30 Jun 2022 report: 91; public on 15 Aug 2022
30 Sep 2022 report: 94; public on 14 Nov 2022
31 Dec 2022 report: 85; public on 14 Feb 2023
31 Mar 2023 report: 86; public on 15 May 2023
30 Jun 2023 report: 83; public on 14 Aug 2023
30 Sep 2023 report: 94; public on 14 Nov 2023
31 Dec 2023 report: 92; public on 14 Feb 2024
31 Mar 2024 report: 106; public on 15 May 2024
30 Jun 2024 report: 106; public on 14 Aug 2024
30 Sep 2024 report: 115; public on 14 Nov 2024
31 Dec 2024 report: 117; public on 14 Feb 2025
31 Mar 2025 report: 115; public on 15 May 2025
30 Jun 2025 report: 117; public on 14 Aug 2025
30 Sep 2025 report: 128; public on 14 Nov 2025
31 Dec 2025 report: 120; public on 17 Feb 2026
31 Mar 2026 report: 122; public on 15 May 2026
30 Jun 2026 report: 139; public on 14 Aug 2026
30 Sep 2026 report: 164; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Jan 2022: $20K published
Quarter from 1 Jul 2022: $30K published
Quarter from 1 Oct 2022: $30K published
Quarter from 1 Jan 2023: $30K published
Quarter from 1 Apr 2023: $20K published
Quarter from 1 Jul 2023: $5K published
Quarter from 1 Apr 2026: $40K published
Quarter from 1 Jul 2026: $40K published
Quarter from 1 Oct 2026: $40K published
What is unusual now
Made public in the last 90 days: it saw 47 13F filers open a new position in the quarter ended 30 Sep 2026, 2.0× the same quarter last year.
Many funds opening a new position: saw 47 13F filers open a new position in the quarter ended 30 Sep 2026, 2.0× the same quarter last year Public on 16 Nov 2026.
Reported lobbying spend: $40K in Q3 2026, $40K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.
Date
Change
Lobbying firm
Issue
Source
1 Jan 2026
New
Integrus Strategies, LLCfor Axadvocacy Government Relations On Behalf Of Strata Critical
Issues related to FAA regulations governing Part 135 operations, including duty and rest requirements for organ transportation flights. Issues related to healthcare policy affecting organ transplant logistics and services.Aviation, Health issues, Transportation
Axadvocacy Government Relationsfor Strata Critical
Issues related to FAA regulations governing Part 135 operations, including duty and rest requirements for organ transportation flights. Issues related to healthcare policy affecting organ transplant logistics and services.Aviation, Health issues, Transportation
Ms. Michelle Nawarfor Bolton-St. Johns LLC On Behalf Of Blade Air Mobility, Inc.
Monitoring and outreach related to: -H.R.1071, Safe and Quiet Skies Act; -H.R.1257, Reducing Helicopter Noise in the District of Columbia Act; -H.R. 3921, Reduce Excessive Decibels and Unwanted Commotion and Emissions to Heighten Enforcement and Limitation of Intrusive Chopper Operations to ProtectAviation, CAW, Transportation
Monitoring and outreach related to: -H.R.1071, Safe and Quiet Skies Act; -H.R.1257, Reducing Helicopter Noise in the District of Columbia Act; -H.R. 3921, Reduce Excessive Decibels and Unwanted Commotion and Emissions to Heighten Enforcement and Limitation of Intrusive Chopper Operations to ProtectAviation, CAW, Transportation
Ms. Michelle Nawarfor Bolton-St. Johns LLC On Behalf Of Blade Air Mobility, Inc.
Issues related to H.R. 1643, Improving Helicopter Safety Act of 2021. Issues related to H.R. 7769, To establish a commission to develop a helicopter usage management plan for certain airspace, and for other purposes.Aviation, Transportation
Issues related to H.R. 1643, Improving Helicopter Safety Act of 2021. Issues related to H.R. 7769, To establish a commission to develop a helicopter usage management plan for certain airspace, and for other purposes.Aviation, Transportation
Changes and notable records, by the date each became public
16 Nov 2026Institutional holdings change
saw 47 13F filers open a new position in the quarter ended 30 Sep 2026, 2.0× the same quarter last year.
Same quarter last year: 23; its normal quarter is 16.
See the evidence
This period
47 (the quarter ended 30 Sep 2026)
Normal quarter (median of 8 earlier)
16
Typical spread (median absolute deviation)
3
How far from its usual level
+7.0
Same quarter last year
23
History used
2,009 days
the quarter ended 30 Sep 20268 earlier quartersnormal: 16
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
spent $9.3M on capital projects in the quarter ended 30 Sep 2024, 13× the same quarter last year.
Same quarter last year: $695K; its normal quarter is $670K.
See the evidence
This period
$9.3M (the quarter ended 30 Sep 2024)
Normal quarter (median of 8 earlier)
$670K
Typical spread (median absolute deviation)
$314K
How far from its usual level
+8.6
Same quarter last year
$695K
History used
1,279 days
the quarter ended 30 Sep 20248 earlier quartersnormal: $670K
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.
spent $16.2M on capital projects in the quarter ended 30 Jun 2024, 22× the same quarter last year.
Same quarter last year: $744K; its normal quarter is $542K.
See the evidence
This period
$16.2M (the quarter ended 30 Jun 2024)
Normal quarter (median of 8 earlier)
$542K
Typical spread (median absolute deviation)
$238K
How far from its usual level
+15.6
Same quarter last year
$744K
History used
1,187 days
the quarter ended 30 Jun 20248 earlier quartersnormal: $542K
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.
reported revenue of $45.7M for the quarter ended 30 Sep 2022, 2.3× the same quarter last year.
Same quarter last year: $20.3M; its normal quarter is $13.0M.
See the evidence
This period
$45.7M (the quarter ended 30 Sep 2022)
Normal quarter (median of 7 earlier)
$13.0M
Typical spread (median absolute deviation)
$7.4M
How far from its usual level
+3.0
Same quarter last year
$20.3M
History used
822 days
the quarter ended 30 Sep 20227 earlier quartersnormal: $13.0M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
Showing the newest 40 of 42 entries; narrow the window or the kind of data to see older ones.
Not listed: 152 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0001779128
Ticker
SRTA
Domain
stratacritical.com
Hq location
NY|NEW YORK|10017 (1 unverified)
Lobbying client
axadvocacy government relations on behalf of strata critical, blade air mobility, blade urban air mobility, bolton st johns llc on behalf of blade air mobility and 1 more
Name
Blade Air Mobility, Inc., Experience Investment Corp., Keystone Perfusion Services LLC, Strata Critical, Inc and 3 more
Federal lobbying disclosures (LDA)8 records, 33 data points7 Jun 2021 to 30 Sep 2026
SEC Form 13F institutional holdings207 data points31 Mar 2021 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)92 records23 Aug 2019 to 3 Nov 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)451 data points30 Sep 2018 to 26 Oct 2026
SEC Form 4 insider transactions83 records, 168 data points11 May 2021 to 9 Nov 2026
FINRA short interest (twice monthly)87 data points29 Aug 2025 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)620 data points29 Aug 2025 to 20 Nov 2026